Author

Jennifer Jones 1

1 Queen Elizabeth II Health Sciences Center,Halifax,Canada

ETROLIZUMAB AS INDUCTION THERAPY IN MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM BERGAMOT COHORT 1

William Sandborn, Julian Panés, Jennifer Jones, Azra Hassanali, Rhian Jacob, Zaineb Sharafali, Young S. Oh, Swati Tole

IMPACT OF CONCOMITANT IMMUNOMODULATOR TREATMENT ON EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN CROHN’S DISEASE: A META-ANALYSIS OF PLACEBO CONTROLLED TRIALS WITH INDIVIDUAL PATIENT-LEVEL DATA

Jennifer Jones, Laurent Peyrin-Biroulet, L Baidoo, Shane Devlin, Gil Y. Melmed, D Tanyingoh, L Raffals, Peter Irving, Patricia Kozuch, Miles P. Sparrow, Fernando Velayos, Brian Bressler, A Cheifetz, Jean-Frederic Colombel, Corey A Siegel, Gilaad G. Kaplan

THE APPROPRIATENESS OF TESTING AND INTERPRETATION OF ANTI-TNF DRUG AND ANTIBODY CONCENTRATIONS: WHEN SHOULD THEY BE ORDERED, AND WHAT TO DO WITH THE RESULTS?

Gil Y. Melmed, Peter Irving, Gilaad G. Kaplan, Brian Bressler, Jennifer Jones, Patricia Kozuch, Miles P. Sparrow, Fernando Velayos, Leonard Baidoo, Adam Cheifetz, Shane Devlin, Laura Raffals, Niels Casteele, Diane R. Mould, William Sandborn, Corey A Siegel

Item 1 - 3 / 3
1